Clozapine therapy for a patient with a history of Hodgkin's disease [3]

Psychiatric Services

Volumn 52, Issue 1, 2001, Pages 110-111

  Miller, P R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; RISPERIDONE; VALPROIC ACID;

ADULT; CASE REPORT; DISEASE PREDISPOSITION; FEMALE; HODGKIN DISEASE; HUMAN; LETTER; LEUKOCYTE COUNT; LEUKOPENIA; MANIC DEPRESSIVE PSYCHOSIS; PSYCHIATRIC TREATMENT; REMISSION;

ADULT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CLOZAPINE; DRUG THERAPY, COMBINATION; FEMALE; HODGKIN DISEASE; HUMANS; LEUKOPENIA; REMISSION INDUCTION; RISPERIDONE; TREATMENT OUTCOME; VALPROIC ACID;

EID: 0035153613     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ps.52.1.110     Document Type: Letter

References (4)

1. Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine
2. Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia
3. Leukopenia, neutropenia, and reduced hemoglobin levels in healthy American blacks
4. Effects of switching inpatients with treatment-resistant schizophrenia from clozapine to risperidone